Today, the Cystic Fibrosis Foundation announced that it has awarded up to $2.17 million to Beyond Air® to support the development of a portable inhaled nitric oxide treatment for nontuberculous mycobacteria, difficult-to-treat bacteria that infect the lungs of people with cystic fibrosis.
Site Search
Showing 71 - 80 of 152 results
Press Release
|
Feb. 16, 2021
|
4 min read
Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies
Press Release
|
Jan. 26, 2022
|
4 min read
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. Join the team that’s adding tomorrows.
3 min read
Press Release
|
June 17, 2020
|
4 min read
Learn more about our Board and Officer Conflict of Interest Policy.
7 min read
Learn more about the Cystic Fibrosis Foundation’s Code of Ethics.
7 min read
Breadth of expertise in business, philanthropy, community engagement, and venture capital to help advance Foundation’s mission
Press Release
|
Aug. 9, 2023
|
4 min read
By educating elected officials and other government decision-makers on the needs of the cystic fibrosis community, the Cystic Fibrosis Foundation works to shape public policy to help our efforts to cure CF and provide all people with CF the opportunity to live full, healthy lives. Below find a listing of our state and federal statements, letters, and regulatory comments.
Groups urging need for revitalizing antimicrobial development call for passage of the bill this year
Press Release
|
April 27, 2023
|
3 min read
Our vendors play a vital role in helping us fulfill our mission at the Cystic Fibrosis Foundation. As such, we aim to build mutually beneficial relationships with all our vendors while holding them to the same high standards we hold ourselves to. Learn more about these standards, and find other helpful documents and information.